Biotechnology

Tevogen Bio

Tevogen Bio released FY2026 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.6124 (forecast USD -2.5)

Tevogen Bio released FY2025 Q4 earnings on March 31 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.3454 (forecast USD -1.5)

Tevogen Bio released FY2025 annual earnings on March 31 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -8.0804 (forecast USD -7.5)

Tevogen Bio released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.4952 (forecast USD -3)

Tevogen Bio released FY2025 9 Months Earnings on November 14 (EST), with actual revenue of USD 0 and EPS of USD -6.2795

Tevogen Bio Holdings Reports Reduced Operating Loss in Q3 2025

Tevogen Bio makes major progress in TVGN 489 clinical trial for acute and post-COVID conditions

Tevogen Projects $6.5B in Revenue for Liver Cancer Prevention Product TVGN 116 in Five Years

Tevogen Bio released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0299 (forecast USD -0.05)

Tevogen Bio released FY2025 Semi-Annual earnings on August 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD -4.5

Tevogen Announces TVGN 489 Drug Clinical Trial

Tevogen Bio Holdings Inc to receive $1 million grant to advance AI development

Tevogen Bio Expands AI Platform to Enhance Clinical Trial Efficiency

Tevogen Bio Opens New Headquarters in New Jersey

Tevogen Bio signs 50M USD Common Stock Sales Agreement with A.G.P.

Tevogen Founder Donates $500,000 to Support Company Construction and Operations

Tevogen Bio Relocates Headquarters to Warren, New Jersey

Tevogen Bio Holdings Inc Submits Up to $150 Million Shelf Registration

Tevogen Bio Advances EBV-Specific T-Cell Therapy Preclinical Study

Tevogen Bio Holdings CEO Reports Disposition of Common Stock

Akanda

Agape ATP

Co-Diagnostics

NewGenIvf

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Tradr 2X Long QBTS Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Tradr 2X Long RGTI Daily ETF

LAFAYETTE ACQUISITION CORP ORD USD0.0001(S/R)24/10/2030

Netcapital

Pinned News

置顶新闻

Tevogen signs LOI to evaluate acquisition of management services organization

TVGNW

TVGN

SBIO

IBBQ

LABU

Tevogen Bio Holdings has signed a non-binding letter of intent to evaluate acquiring a management services organization, aiming to enhance its healthcare infrastructure and expand into healthcare services. This move, along with other acquisition efforts, could potentially lead to $100 million in annual revenue if successful, pending due diligence and approvals.

PUBT

TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)

ALPS Medical Breakthrough

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Invesco Nasdaq Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Tevogen Bio Holdings shares are trading higher after the company announced it signed a non-binding Letter of Intent to evaluate a potential transaction with a Management Services Organization.

benzinga_article

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization | TVGN Stock News

StockTitan

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization | TVGN Stock News

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

Direxion S&P Biotech Bear 3X

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

QUCY

STAA

WGRX

DOCS

IPHA

MDXH

In Thursday's pre-market session, several health care stocks experienced significant movements. Alpha Compute (ALP) surged 71.3% to $0.46, while Innate Pharma (IPHA) rose 24.24% to $1.64. Quantum Cyber (QUCY) increased by 23.88% to $1.66, and Staar Surgical (STAA) gained 21.32% to $35.67. Conversely, MDxHealth (MDXH) fell 41.0% to $1.15, and WORK Medical Tech (WOK) dropped 27.9% to $1.99. Other notable losers included Doximity (DOCS) down 23.43% to $17.91 and Wellgistics Health (WGRX) down 17.53% to $0.08. Earnings reports influenced these movements.

Quantum Cyber NV

STAAR Surgical

Alpha Compute

WORK Medical Tech

Wellgistics Health

Doximity

Innate Pharma SA

MDxHealth SA

GT Biopharma

Cormedix

Regenxbio

Sunshine Biopharma

Mainz Biomed NV

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close | TVGN Stock News

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close | TVGN Stock News

Tevogen Bio Holdings Inc. (TVGN) is nearing completion of its AI model, PredicTcell, which is designed to identify immunologically active peptides for drug discovery. The model has shown a 10% improvement in precision and the company is exploring co-development partnerships to enhance its application. An internal application for PredicTcell has been developed, aiming to streamline workflows and potentially serve customers. The company also executed a 1-for-50 reverse stock split, with shares closing at $7.00, down 7.28%.

nasdaq

Nasdaq

Tevogen.AI's PredicTcell Model Nears Completion As Company Begins Commercial Readiness Work

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | TVGN Stock News

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | TVGN Stock News

Tevogen Bio(TVGN.US)

Tevogen signs LOI to evaluate acquisition of management services organization

Tevogen Bio Holdings shares are trading higher after the company announced it signed a non-binding Letter of Intent to evaluate a potential transaction with a Management Services Organization.

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization | TVGN Stock News

Letter to Shareholders from CEO Dr. Ryan Saadi | TVGN Stock News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close | TVGN Stock News

Tevogen.AI's PredicTcell Model Nears Completion As Company Begins Commercial Readiness Work

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal | TVGN Stock News

Trending